Verseon Gains US Patent Protection for Compounds that Could Eliminate Bleeding Risks of Current Anticoagulants
/PRNewswire/ -- Verseon is pleased to announce that the USPTO has issued a new patent, "Thrombin Inhibitors, Formulations, and Uses Thereof," that further...
Walter Jones David Kita Prnewswire Verseon Verseon International Corporation Uses Thereof Precision Oral Anticoagulants
Source: prnewswire.com